Consistently, immunohistochemical analysis showed a decrease in Ki-67 and an increase in cleaved caspase 3 in tumor-invaded bone sections by the administration of CALR (Figure 5—figure supplement 1). This evidence concerns the gene MKI67 and neoplasm.